13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q1 2023. See the latest, Q2 2026 →
Reported value
$483.79B
+3.1% on the quarter before
Positions
513
19 new · 45 sold out
Top 10
25.4%
of the value
Est. gain
+$20.75B
on stocks held all quarter
Est. return
+4.9%
on those stocks since Q4 2022
Positions as of Mar 31, 2023, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 41% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2022. Striped tiles are options.
Largest buys
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$4.18BNew · 0.0% → 0.9%+11,765,704 shares
- Salesforce~$2.71BAdded · 0.0% → 0.6%+13,582,939 shares
- Te Connectivity Ltd~$1.59BAdded · 0.6% → 0.9%+12,092,737 shares
- Goldman Sachs~$1.34BAdded · 0.4% → 0.7%+4,090,511 shares
- Philip Morris Intl Inc~$1.18BAdded · 2.2% → 2.2%+12,132,787 shares
- Meta~$1.09BAdded · 0.8% → 1.6%+5,147,768 shares
- Vertex Pharmaceuticals Inc~$1.06BAdded · 0.8% → 1.1%+3,375,417 shares
- Seagen Inc~$1.01BAdded · 0.2% → 0.5%+5,009,389 shares
- Mosaic Co New~$1.01BAdded · 0.2% → 0.4%+22,007,649 shares
- FirstEnergy~$1.01BAdded · 0.0% → 0.2%+25,112,781 shares
Largest sells
Since Q4 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Linde Plc~$4.14BSold out · 0.9% → 0.0%−12,697,605 shares
- Pioneer Nat Res Co~$1.81BCut · 0.9% → 0.4%−8,871,867 shares
- Cvs Health Corp~$1.78BCut · 1.1% → 0.5%−23,905,817 shares
- Archer Daniels Midland Co~$1.72BCut · 0.8% → 0.3%−21,547,383 shares
- Jpmorgan Chase & Co~$1.63BCut · 1.5% → 1.1%−12,527,638 shares
- Broadcom~$1.29BCut · 3.5% → 3.6%−2,012,100 shares
- Microsoft~$1.18BCut · 4.7% → 5.2%−4,106,083 shares
- Pfizer Inc~$1.00BCut · 2.8% → 2.0%−24,584,436 shares
- Tesla~$969.0MCut · 1.3% → 1.9%−4,671,123 shares
- Wells Fargo Co New~$946.0MCut · 0.5% → 0.3%−25,306,935 shares
Holdings
As of Mar 31, 2023. Changes are in shares against Dec 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −4.5% · price +20.2% | 5.2% | $25.26B | +$4.25B | ||||||||
| BroadcomCOM · shares −6.9% · price +14.7% | 3.6% | $17.55B | +$2.25B | ||||||||
| Unitedhealth Group IncCOM · shares −4.3% · price −10.9% | 2.9% | $13.89B | −$1.69B | ||||||||
| Home Depot IncCOM · shares +0.9% · price −6.6% | 2.4% | $11.66B | −$813.3M | ||||||||
| Philip Morris Intl IncCOM · shares +12% · price −3.9% | 2.2% | $10.87B | −$394.8M | ||||||||
| Eli LillyCOM · shares −2.1% · price −6.1% | 2.0% | $9.47B | −$618.7M | ||||||||
| Pfizer IncCOM · shares −9.6% · price −20.4% | 2.0% | $9.45B | −$2.42B | ||||||||
| TeslaCOM · shares −9.6% · price +68.4% | 1.9% | $9.08B | +$3.69B | ||||||||
| Canadian Nat Res LtdCOM · shares −0.8% · price −0.3% | 1.7% | $8.28B | −$28.8M | ||||||||
| MetaCL A · shares +17% · price +76.1% | 1.6% | $7.52B | +$2.78B | ||||||||
| Thermo Fisher Scientific IncCOM · shares −4.6% · price +4.7% | 1.5% | $7.45B | +$331.7M | ||||||||
| Caterpillar IncCOM · shares −1.1% · price −4.5% | 1.4% | $6.59B | −$308.8M | ||||||||
| Gilead Sciences IncCOM · shares +11% · price −3.4% | 1.3% | $6.35B | −$198.5M | ||||||||
| Target CorpCOM · shares +14% · price +11.1% | 1.2% | $5.98B | +$527.0M | ||||||||
| AlphabetCAP STK CL C · shares +10% · price +17.2% | 1.1% | $5.45B | +$726.5M | ||||||||
| Jpmorgan Chase & CoCOM · shares −24% · price −2.8% | 1.1% | $5.28B | −$153.7M | ||||||||
| AppleCOM · shares +8.2% · price +26.9% | 1.1% | $5.28B | +$1.03B | ||||||||
| Vertex Pharmaceuticals IncCOM · shares +26% · price +9.1% | 1.1% | $5.09B | +$335.7M | ||||||||
| Booking Holdings IncCOM · shares +2.3% · price +31.6% | 1.0% | $5.04B | +$1.18B | ||||||||
| Regeneron PharmaceuticalsCOM · shares −6.6% · price +13.9% | 0.99% | $4.79B | +$584.1M | ||||||||
| Asml Holding N VN Y REGISTRY SHS · shares +1.1% · price +24.6% | 0.96% | $4.67B | +$910.5M | ||||||||
| Te Connectivity LtdSHS · shares +53% · price +14.2% | 0.94% | $4.56B | +$371.1M | ||||||||
| Lockheed Martin CorpCOM · shares −15% · price −2.8% | 0.91% | $4.38B | −$127.6M | ||||||||
| Linde PlcSHS · shares New | 0.86% | $4.18B | — | ||||||||
| Applied MaterialsCOM · shares −5.3% · price +26.1% | 0.83% | $4.03B | +$835.6M | ||||||||
| Total · 513 positions | 100% | $483.79B | +$20.75B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2022 to Q1 2023: 490 stocks held throughout, up $20.75B (+4.9%).
- Microsoft+$4.25B+20%
- Tesla+$3.69B+68%
- Meta+$2.78B+76%
- Broadcom+$2.25B+15%
- Booking Holdings Inc+$1.18B+32%
- Eli Lilly−$618.7M−6%
- Home Depot Inc−$813.3M−7%
- Centene Corp Del−$936.3M−23%
- Unitedhealth Group Inc−$1.69B−11%
- Pfizer Inc−$2.42B−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |